Kollins John A [Rocket]

Date Filed

Type

Description

06/08/2023

Kollins John A (President and CEO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.

Txns:

Unknown transaction of 305,911 shares @ $0.91, valued at $278.4k
Disposed/sold 175,000 options to buy @ $29, valued at $5.1M
Disposed/sold 240,000 options to buy @ $4.6, valued at $1.1M
Disposed/sold 505,000 options to buy @ $3.46, valued at $1.7M
Disposed/sold 276,595 options to buy @ $4.56, valued at $1.3M
Disposed/sold 127,659 options to buy @ $1.04, valued at $132.8k
Disposed/sold 127,659 options to buy @ $0.9, valued at $114.9k

06/07/2022

4

Form 4 - Statement of changes in beneficial ownership of securities:

12/07/2020

4

Kollins John A (President and CEO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.

Txns:

Granted 240,000 options to buy @ $4.6, valued at $1.1M

03/06/2020

4

Form 4 - Statement of changes in beneficial ownership of securities:

10/30/2014

4

Kollins John A (SVP, Chief Business Officer) has filed a Form 4 on Transcept Pharmaceuticals Inc

Txns:

Granted 4,161 shares @ $21.588, valued at $89.8k
Disposed/sold 4,166 options to buy @ $0
Disposed/sold 7,083 options to buy @ $0
Disposed/sold 7,500 options to buy @ $0
Disposed/sold 9,583 options to buy @ $0

06/05/2014

4

Form 4 - Statement of changes in beneficial ownership of securities

07/18/2013

4

Form 4 - Statement of changes in beneficial ownership of securities

01/08/2013

4

Kollins John A (SVP, Chief Business Officer) has filed a Form 4 on Transcept Pharmaceuticals Inc

Txns:

Granted 90,000 options to buy @ $5.4, valued at $486k

06/21/2012